| 1 | Hodgkin Disease | 46.7% |
| 2 | Lymphoma, Non-Hodgkin | 46.7% |
| 3 | Sezary Syndrome | 35.4% |
| 4 | Lymphoma, Follicular | 34.7% |
| 5 | T-Cell Lymphoma | 34.7% |
| 6 | Mantle cell lymphoma | 34.7% |
| 7 | Carcinosarcoma | 31.7% |
| 8 | Lymphomatoid Granulomatosis | 30.4% |
| 9 | Lymphoma, T-Cell, Cutaneous | 28.8% |
| 10 | Lymphoma, AIDS-Related | 28.8% |
| 11 | Enteropathy-Associated T-Cell Lymphoma | 28.8% |
| 12 | Primary Effusion Lymphoma | 28.8% |
| 13 | Neoplasms, Neuroepithelial | 28% |
| 14 | Gliomatosis cerebri | 28% |
| 15 | Medulloblastoma | 26.9% |
| 16 | Carcinoma 256, Walker | 26.8% |
| 17 | Neuroectodermal Tumors | 26.4% |
| 18 | Mesenchymoma | 26.3% |
| 19 | Hepatoblastoma | 26.3% |
| 20 | Mixed Tumor, Mullerian | 26.3% |
| 21 | Leukemia, Plasma Cell | 26.2% |
| 22 | Lymphangioleiomyomatosis | 26% |
| 23 | Mycosis Fungoides | 25.9% |
| 24 | Lymphomatoid Papulosis | 25.9% |
| 25 | Plasmablastic lymphoma | 25.9% |
| 26 | Thymoma | 25.8% |
| 27 | melanoma | 25.1% |
| 28 | Histiocytic Disorders, Malignant | 25% |
| 29 | Plasmacytoma | 24.7% |
| 30 | leukemia | 24% |
| 31 | Neoplasms, Germ Cell and Embryonal | 24% |
| 32 | Neoplasms, Glandular and Epithelial | 24% |
| 33 | Germ Cell Cancer | 24% |
| 34 | Tumor Lysis Syndrome | 23.1% |
| 35 | Hemangiosarcoma | 23% |
| 36 | lymphangiosarcoma | 23% |
| 37 | Burkitt Lymphoma | 22.5% |
| 38 | Endometrial Stromal Sarcoma | 22.2% |
| 39 | Adenoma, Acidophil | 22.2% |
| 40 | Ganglioneuroma | 22.2% |
| 41 | Glioma | 22.2% |
| 42 | Primary amyloidosis | 22.2% |
| 43 | Malignant Glioma | 22.2% |
| 44 | Meningioma | 21.7% |
| 45 | Leukemia, T-Cell | 21.4% |
| 46 | Leukemia, B-Cell | 21.4% |
| 47 | Carcinoid Tumor | 20.8% |
| 48 | Neurilemmoma | 20.8% |
| 49 | Hutchinson's Melanotic Freckle | 20.8% |
| 50 | Melanoma, Amelanotic | 20.8% |
| 51 | Melanoma, Experimental | 20.7% |
| 52 | Autoimmune Lymphoproliferative Syndrome | 19.7% |
| 53 | Basal cell carcinoma | 19.6% |
| 54 | Carcinoma, Papillary | 19.6% |
| 55 | Squamous cell carcinoma | 19.6% |
| 56 | Chondrosarcoma | 19.6% |
| 57 | Craniopharyngioma | 19.6% |
| 58 | Cystadenoma | 19.6% |
| 59 | leiomyosarcoma | 19.6% |
| 60 | liposarcoma | 19.6% |
| 61 | Mesothelioma | 19.6% |
| 62 | synovial sarcoma | 19.6% |
| 63 | Neuroectodermal Tumor, Melanotic | 19.6% |
| 64 | Angiomyolipoma | 19.6% |
| 65 | Clear Cell Sarcoma of Soft Tissue | 19.6% |
| 66 | Alveolar Soft Part Sarcoma | 19.6% |
| 67 | Neuroendocrine Tumors | 19.6% |
| 68 | Sarcoma, Myeloid | 19.6% |
| 69 | Carcinoma, Basal Cell | 19.6% |
| 70 | Astrocytoma | 19.4% |
| 71 | Ependymoma | 19.4% |
| 72 | oligodendroglioma | 19.4% |
| 73 | Ganglioglioma | 19.4% |
| 74 | gliosarcoma | 19.4% |
| 75 | Anaplastic astrocytoma | 19.4% |
| 76 | Anaplastic Oligodendroglioma | 19.4% |
| 77 | Waldenstrom Macroglobulinemia | 19.1% |
| 78 | Multiple Myeloma | 19.1% |
| 79 | Malignant Carcinoid Syndrome | 18.6% |
| 80 | Infectious Mononucleosis | 18.5% |
| 81 | Glioblastoma | 17.9% |
| 82 | Neuroblastoma | 17.9% |
| 83 | Glioblastoma Multiforme | 17.9% |
| 84 | Cystadenocarcinoma | 17.9% |
| 85 | Fibrosarcoma | 17.9% |
| 86 | Osteosarcoma | 17.9% |
| 87 | Mucoepidermoid Carcinoma | 17.9% |
| 88 | Ganglioneuroblastoma | 17.2% |
| 89 | Trophoblastic Neoplasms | 17.1% |
| 90 | Leukemia, Experimental | 17.1% |
| 91 | Adenofibroma | 17.1% |
| 92 | Fibroadenoma | 17.1% |
| 93 | Malignant Fibrous Histiocytoma | 17.1% |
| 94 | Choriocarcinoma | 16.7% |
| 95 | Carcinoma, Lobular | 16.7% |
| 96 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 16.6% |
| 97 | Leukemia, Large Granular Lymphocytic | 16.6% |
| 98 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 16.6% |
| 99 | Carcinoma, Ehrlich Tumor | 16.6% |
| 100 | Dermoid Cyst | 16.6% |
| 101 | Carcinoma, Lewis Lung | 16.6% |
| 102 | Malignant histiocytosis | 16.4% |
| 103 | Histiocytic sarcoma | 16.4% |
| 104 | Lymphoma, Extranodal NK-T-Cell | 16.3% |
| 105 | Bowen's Disease | 16.2% |
| 106 | Paraganglioma | 16.2% |
| 107 | Rhabdomyosarcoma | 16.2% |
| 108 | Giant Cell Tumor of Bone | 16.2% |
| 109 | Retinoblastoma | 16.1% |
| 110 | Adenoma | 15.8% |
| 111 | Ameloblastoma | 15.8% |
| 112 | Angiokeratoma | 15.8% |
| 113 | Carcinoma | 15.8% |
| 114 | Chordoma | 15.8% |
| 115 | Hemangioma | 15.8% |
| 116 | hemangiopericytoma | 15.8% |
| 117 | Lymphangioma | 15.8% |
| 118 | Nevus | 15.8% |
| 119 | Teratoma | 15.8% |
| 120 | Germinoma | 15.8% |
| 121 | Teratocarcinoma | 15.8% |
| 122 | Angiofibroma | 15.8% |
| 123 | Sarcoma | 15.8% |
| 124 | Epithelioma | 15.8% |
| 125 | Carcinoid Heart Disease | 15.6% |
| 126 | Nephroblastoma | 15.6% |
| 127 | Neurofibrosarcoma | 15.5% |
| 128 | Dermatofibrosarcoma | 15.4% |
| 129 | Dermatofibrosarcoma Protuberans | 15.4% |
| 130 | Lymphocele | 15.2% |
| 131 | Leukemia, Radiation-Induced | 15.1% |
| 132 | Heavy Chain Disease | 15% |
| 133 | Mesoblastic Nephroma | 14.6% |
| 134 | Pheochromocytoma | 14.6% |
| 135 | Alveolar rhabdomyosarcoma | 14.6% |
| 136 | Leukemia L1210 | 14.2% |
| 137 | Leukemia P388 | 14.2% |
| 138 | Acanthoma | 14.2% |
| 139 | Sarcoma, Experimental | 14.2% |
| 140 | Sarcoidosis | 13.8% |
| 141 | Agammaglobulinemia | 13.8% |
| 142 | Hamartoma | 13.7% |
| 143 | Neoplasms, Hormone-Dependent | 13.7% |
| 144 | Neoplasms, Multiple Primary | 13.7% |
| 145 | Paraneoplastic Syndromes | 13.7% |
| 146 | Precancerous Conditions | 13.7% |
| 147 | Neoplasms, Second Primary | 13.7% |
| 148 | Acoustic Neuroma | 12.9% |
| 149 | Thymus Neoplasms | 12.8% |
| 150 | Sarcoma 180 | 12.5% |
| 151 | Multiple Endocrine Neoplasia | 12% |
| 152 | Carcinoma, Pancreatic Ductal | 12% |
| 153 | Basal Cell Nevus Syndrome | 11.9% |
| 154 | Optic Nerve Glioma | 11.8% |
| 155 | Adenocarcinoma | 11.8% |
| 156 | Carcinoma in Situ | 11.8% |
| 157 | Carcinoma, Transitional Cell | 11.8% |
| 158 | Phyllodes Tumor | 11.8% |
| 159 | Dysgerminoma | 11.8% |
| 160 | Hemangioendothelioma | 11.8% |
| 161 | Lipoma | 11.8% |
| 162 | Myoma | 11.8% |
| 163 | Myxoma | 11.8% |
| 164 | Neuroma | 11.8% |
| 165 | Papilloma | 11.8% |
| 166 | Pseudomyxoma Peritonei | 11.8% |
| 167 | Seminoma | 11.8% |
| 168 | Papillomatosis | 11.8% |
| 169 | Angiolipoma | 11.8% |
| 170 | Myelolipoma | 11.8% |
| 171 | Neoplasms, Bone Tissue | 11.8% |
| 172 | Neoplasms, Fibrous Tissue | 11.8% |
| 173 | Smooth Muscle Tumor | 11.8% |
| 174 | Adenomatosis, Pulmonary | 11.8% |
| 175 | Adenomatous Polyps | 11.8% |
| 176 | Carcinoma, Large Cell | 11.8% |
| 177 | Carcinoma, Small Cell | 11.8% |
| 178 | Desmoplastic Small Round Cell Tumor | 11.8% |
| 179 | Chondroma | 11.8% |
| 180 | Enchondroma | 11.8% |
| 181 | Granuloma | 11.7% |
| 182 | Splenic Neoplasms | 11.7% |
| 183 | Cyst | 11.5% |
| 184 | Neoplastic Processes | 11.5% |
| 185 | Neoplastic Syndromes, Hereditary | 11.5% |
| 186 | Pregnancy Complications, Neoplastic | 11.5% |
| 187 | Neoplasms, Experimental | 11.4% |
| 188 | Leukemia, Myelomonocytic, Chronic | 10.9% |
| 189 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 10.9% |
| 190 | Vipoma | 10.8% |
| 191 | Adenitis | 10% |
| 192 | Histiocytosis | 10% |
| 193 | Lymphadenitis | 10% |
| 194 | Lymphangitis | 10% |
| 195 | Lymphedema | 10% |
| 196 | Paraproteinemias | 10% |
| 197 | Splenic Diseases | 10% |
| 198 | Thymus Hyperplasia | 10% |
| 199 | Pseudolymphoma | 10% |
| 200 | Lymphadenopathy | 10% |
| 201 | Mastocytosis | 10% |
| 202 | Hepatocellular Adenoma | 9.8% |
| 203 | Composite Lymphoma | 9.8% |
| 204 | Adenoid Cystic Carcinoma | 9.8% |
| 205 | fibroma | 9.8% |
| 206 | Fibromatosis | 9.8% |
| 207 | Osteoblastoma | 9.8% |
| 208 | Osteoma | 9.8% |
| 209 | Rhabdomyoma | 9.8% |
| 210 | Chondromatosis | 9.8% |
| 211 | Adenocarcinoma, Clear Cell | 9.8% |
| 212 | Cholangiocarcinoma | 9.8% |
| 213 | Cervical Intraepithelial Neoplasia | 9.8% |
| 214 | Hemangioblastoma | 9.8% |
| 215 | Neoplasms, Radiation-Induced | 9.8% |
| 216 | Hydatidiform Mole | 9.7% |
| 217 | Paraneoplastic Encephalomyelitis | 9.6% |
| 218 | Hematologic Neoplasms | 9.6% |
| 219 | Mammary Neoplasms, Experimental | 9.5% |
| 220 | Hemangioma, Cavernous | 9.3% |
| 221 | Tuberous Sclerosis | 9.3% |
| 222 | Mastocytosis, Systemic | 9.2% |
| 223 | Monoclonal Gammopathy of Undetermined Significance | 9% |
| 224 | Leukemia, Myeloid, Chronic-Phase | 8.9% |
| 225 | Fibromatosis, Aggressive | 8.8% |
| 226 | Fibromatosis, Abdominal | 8.8% |
| 227 | Klatskin Tumor | 8.8% |
| 228 | Prolactinoma | 8.7% |
| 229 | Growth Hormone-Secreting Pituitary Adenoma | 8.7% |
| 230 | Hypergammaglobulinemia | 8.7% |
| 231 | Lymphoma | 8.6% |
| 232 | Denys-Drash Syndrome | 8.5% |
| 233 | Sturge-Weber Syndrome | 8.5% |
| 234 | Lymphangiectasis, Intestinal | 8.5% |
| 235 | Gastrointestinal Stromal Tumors | 8.5% |
| 236 | Lymphatic Abnormalities | 8.4% |
| 237 | neurofibroma | 8.4% |
| 238 | Mastocytoma | 8.2% |
| 239 | insulinoma | 8.1% |
| 240 | Transfusion Reaction | 8% |
| 241 | Hypotensive Transfusion Reaction | 8% |
| 242 | Multiple Endocrine Neoplasia Type 1 | 8% |
| 243 | Abdominal Neoplasms | 8% |
| 244 | Erythroplasia | 8% |
| 245 | Follicular cyst | 8% |
| 246 | Head and Neck Neoplasms | 8% |
| 247 | Mucocele | 8% |
| 248 | Pilonidal Cyst | 8% |
| 249 | Soft Tissue Neoplasms | 8% |
| 250 | Thoracic Neoplasms | 8% |
| 251 | Thyroglossal Cyst | 8% |
| 252 | Synovial Cyst | 8% |
| 253 | Aberrant Crypt Foci | 8% |
| 254 | Adenomatous Polyposis Coli | 7.9% |
| 255 | granulosa cell tumor | 7.8% |
| 256 | Carcinoma, Ovarian Epithelial | 7.8% |
| 257 | Sarcoidosis, Pulmonary | 7.7% |
| 258 | Gastrinoma | 7.6% |
| 259 | Glucagonoma | 7.6% |
| 260 | Adrenocortical carcinoma | 7.2% |
| 261 | Leydig Cell Tumor | 7.2% |
| 262 | Mucocutaneous Lymph Node Syndrome | 7.1% |
| 263 | Digestive System Neoplasms | 6.9% |
| 264 | Endocrine Gland Neoplasms | 6.9% |
| 265 | Eye Neoplasms | 6.9% |
| 266 | Nervous System Neoplasms | 6.9% |
| 267 | Bone neoplasms | 6.7% |
| 268 | Leukoplakia | 6.7% |
| 269 | Pancreatic Cyst | 6.7% |
| 270 | Skin Neoplasms | 6.7% |
| 271 | Parathyroid Neoplasms | 6.7% |
| 272 | Peritoneal Neoplasms | 6.7% |
| 273 | Thyroid Neoplasm | 6.7% |
| 274 | Thyroid carcinoma | 6.7% |
| 275 | Barrett Esophagus | 6.7% |
| 276 | Breast Cyst | 6.7% |
| 277 | Actinic keratosis | 6.7% |
| 278 | Mediastinal Cyst | 6.7% |
| 279 | Neoplasm Invasiveness | 6.7% |
| 280 | Neoplasm Metastasis | 6.7% |
| 281 | Neoplasm Recurrence, Local | 6.7% |
| 282 | Parovarian Cyst | 6.7% |
| 283 | Pericardial Cyst | 6.7% |
| 284 | Thymic Cyst | 6.7% |
| 285 | Carcinogenesis | 6.7% |
| 286 | Myxoid cyst | 6.7% |
| 287 | Metastasis | 6.7% |
| 288 | Nasopharyngeal carcinoma | 6.6% |
| 289 | Liver Neoplasms, Experimental | 6.6% |
| 290 | Bone Marrow Neoplasms | 6.6% |
| 291 | Renal Cell Carcinoma | 6.5% |
| 292 | Papillary Renal Cell Carcinoma | 6.5% |
| 293 | Dupuytren Contracture | 6.4% |
| 294 | Urticaria Pigmentosa | 6.3% |
| 295 | Carcinoma, Endometrioid | 6.3% |
| 296 | Autoimmune Diseases | 6.2% |
| 297 | Hypersensitivity | 6.2% |
| 298 | Immunologic Deficiency Syndromes | 6.2% |
| 299 | Immune reconstitution syndrome | 6.2% |
| 300 | Immune Reconstitution Inflammatory Syndrome | 6.2% |
| 301 | Pancreatic Neoplasm | 6% |
| 302 | Elephantiasis | 5.9% |
| 303 | Hypersplenism | 5.9% |
| 304 | Elephantiasis Nostras Verrucosa | 5.9% |
| 305 | Tracheal Neoplasms | 5.9% |
| 306 | Leukoplakia, Oral | 5.8% |
| 307 | Paraneoplastic Cerebellar Degeneration | 5.7% |
| 308 | Corpus Luteum Cyst | 5.7% |
| 309 | Ovarian Cysts | 5.7% |
| 310 | Lambert-Eaton Myasthenic Syndrome | 5.6% |
| 311 | Cryoglobulinemia | 5.3% |
| 312 | Retroperitoneal Neoplasms | 5.3% |
| 313 | Esophageal Neoplasms | 5.1% |
| 314 | Limbic Encephalitis | 5.1% |
| 315 | Choledochal Cyst | 5% |
| 316 | Splenic Infarction | 5% |
| 317 | Histiocytosis, Langerhans-Cell | 4.9% |
| 318 | Peutz-Jeghers Syndrome | 4.9% |
| 319 | Thyroid Nodule | 4.9% |
| 320 | Polycythemia Vera | 4.9% |
| 321 | Autoimmune thrombocytopenia | 4.7% |
| 322 | Immune thrombocytopenic purpura | 4.7% |
| 323 | Testicular Neoplasms | 4.7% |
| 324 | Thrombocytopenic purpura | 4.6% |
| 325 | POEMS Syndrome | 4.5% |
| 326 | Mouth Neoplasms | 4.4% |
| 327 | Central Nervous System Neoplasms | 4.4% |
| 328 | Vascular Neoplasms | 4.4% |
| 329 | Genital Neoplasms, Female | 4.4% |
| 330 | Pancreatic Pseudocyst | 4.4% |
| 331 | Lymphatic Metastasis | 4.4% |
| 332 | Myelitis, Transverse | 4.4% |
| 333 | Neoplasms, Unknown Primary | 4.4% |
| 334 | Leukemic Infiltration | 4.4% |
| 335 | Breast Neoplasms, Male | 4.4% |
| 336 | Neoplasm Micrometastasis | 4.4% |
| 337 | Triple Negative Breast Neoplasms | 4.4% |
| 338 | Splenic Rupture | 4.3% |
| 339 | Glomerulonephritis, Membranoproliferative | 4.3% |
| 340 | Disseminated Intravascular Coagulation | 4.2% |
| 341 | Protein S Deficiency | 4.2% |
| 342 | Opsoclonus-Myoclonus Syndrome | 4.2% |
| 343 | Lymphohistiocytosis, Hemophagocytic | 3.9% |
| 344 | Schnitzler Syndrome | 3.9% |
| 345 | Erdheim-Chester Disease | 3.9% |
| 346 | Thrombocythemia, Essential | 3.9% |
| 347 | Lymphopenia | 3.9% |
| 348 | Adrenal Gland Neoplasms | 3.8% |
| 349 | Gastrointestinal Neoplasms | 3.8% |
| 350 | Genital Neoplasms, Male | 3.8% |
| 351 | Liver neoplasms | 3.8% |
| 352 | Uveal Neoplasms | 3.8% |
| 353 | Urologic Neoplasms | 3.8% |
| 354 | Transfusion-Related Acute Lung Injury | 3.8% |
| 355 | Sebaceous Gland Neoplasms | 3.8% |
| 356 | Spinal Neoplasms | 3.8% |
| 357 | Polycystic Ovary Syndrome | 3.7% |
| 358 | Nose Neoplasms | 3.7% |
| 359 | Palatal Neoplasms | 3.6% |
| 360 | Pituitary Adenoma | 3.3% |
| 361 | Pituitary Neoplasms | 3.3% |
| 362 | Anemia | 3.3% |
| 363 | Blood Coagulation Disorders | 3.3% |
| 364 | Blood Platelet Disorders | 3.3% |
| 365 | Bone Marrow Diseases | 3.3% |
| 366 | Hemorrhagic Disorders | 3.3% |
| 367 | Immune Complex Diseases | 3.3% |
| 368 | Leukocyte Disorders | 3.3% |
| 369 | Methemoglobinemia | 3.3% |
| 370 | Pancytopenia | 3.3% |
| 371 | Polycythemia | 3.3% |
| 372 | Sulfhemoglobinemia | 3.3% |
| 373 | Xeroderma Pigmentosum | 3.3% |
| 374 | Antiphospholipid Syndrome | 3.3% |
| 375 | Thrombophilia | 3.3% |
| 376 | Latex allergy | 3.3% |
| 377 | Erythrocytosis | 3.3% |
| 378 | Thrombasthenia | 3.3% |
| 379 | Antithrombin III Deficiency | 3.3% |
| 380 | Protein C Deficiency | 3.3% |
| 381 | Meningeal Neoplasms | 3.3% |
| 382 | Wiskott-Aldrich Syndrome | 3.1% |
| 383 | ovarian neoplasm | 2.9% |
| 384 | Eosinophilic Granuloma | 2.9% |
| 385 | Environmental Illness | 2.9% |
| 386 | Ear Neoplasms | 2.9% |
| 387 | Eyelid Neoplasms | 2.9% |
| 388 | Lung Neoplasms | 2.9% |
| 389 | Pleural Neoplasms | 2.9% |
| 390 | Afibrinogenemia | 2.9% |
| 391 | Factor VII Deficiency | 2.9% |
| 392 | Factor X Deficiency | 2.9% |
| 393 | Factor XII Deficiency | 2.9% |
| 394 | Hemophilia A | 2.9% |
| 395 | Activated Protein C Resistance | 2.9% |
| 396 | Factor II deficiency | 2.9% |
| 397 | Factor VIII Deficiency | 2.9% |
| 398 | Factor V deficiency | 2.9% |
| 399 | Factor XI Deficiency | 2.9% |
| 400 | Hypoprothrombinemias | 2.9% |
| 401 | Hydrops Fetalis | 2.8% |
| 402 | Cell Transformation, Viral | 2.8% |
| 403 | Brain Neoplasms | 2.8% |
| 404 | Salivary Gland Neoplasms | 2.8% |
| 405 | Spinal Cord Neoplasms | 2.8% |
| 406 | Tongue Neoplasms | 2.8% |
| 407 | Splenosis | 2.8% |
| 408 | Vitamin K Deficiency | 2.8% |
| 409 | Lupus Erythematosus, Systemic | 2.8% |
| 410 | Pregnancy Complications, Hematologic | 2.8% |
| 411 | Overlap syndrome | 2.8% |
| 412 | Uterine Neoplasms | 2.8% |
| 413 | Vaginal Neoplasms | 2.8% |
| 414 | Vulvar Neoplasms | 2.8% |
| 415 | Uterine Cancer | 2.8% |
| 416 | Fallopian Tube Neoplasms | 2.8% |
| 417 | Addison Disease | 2.8% |
| 418 | Pemphigus | 2.8% |
| 419 | Autoimmune thyroiditis | 2.8% |
| 420 | Primary Adrenal Insufficiency | 2.8% |
| 421 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.8% |
| 422 | Autoimmune hepatitis | 2.8% |
| 423 | Thrombocytosis | 2.7% |
| 424 | Job Syndrome | 2.7% |
| 425 | Meningeal Carcinomatosis | 2.7% |
| 426 | Kernicterus | 2.7% |
| 427 | Pharyngeal Neoplasms | 2.5% |
| 428 | Central Nervous System Cysts | 2.5% |
| 429 | Bile Duct Neoplasms | 2.5% |
| 430 | gallbladder neoplasm | 2.5% |
| 431 | Intestinal Neoplasms | 2.5% |
| 432 | Penile Neoplasms | 2.5% |
| 433 | Prostatic Neoplasms | 2.5% |
| 434 | Stomach Neoplasms | 2.5% |
| 435 | Latent Autoimmune Diabetes in Adults | 2.4% |
| 436 | Zollinger-Ellison syndrome | 2.4% |
| 437 | Dermatitis Herpetiformis | 2.4% |
| 438 | Kounis Syndrome | 2.4% |
| 439 | HIV Infections | 2.4% |
| 440 | Bronchial Neoplasms | 2.4% |
| 441 | Chronic granulomatous disease | 2.3% |
| 442 | Multiple Pulmonary Nodules | 2.3% |
| 443 | Supratentorial Neoplasms | 2.3% |
| 444 | Endometrial Neoplasms | 2.3% |
| 445 | Laryngeal neoplasm | 2.3% |
| 446 | Asthma, Aspirin-Induced | 2.2% |
| 447 | Bladder Neoplasm | 2.2% |
| 448 | Kidney Neoplasm | 2.2% |
| 449 | Ureteral Neoplasms | 2.2% |
| 450 | Urethral Neoplasms | 2.2% |
| 451 | Hemoglobinuria, Paroxysmal | 2.2% |
| 452 | Leukemoid Reaction | 2.2% |
| 453 | Rheumatoid Arthritis | 2.1% |
| 454 | Juvenile arthritis | 2.1% |
| 455 | Graves Disease | 2.1% |
| 456 | Brain Stem Neoplasms | 2.1% |
| 457 | Purpura, Thrombotic Thrombocytopenic | 2.1% |
| 458 | Anti-Glomerular Basement Membrane Disease | 2.1% |
| 459 | Hypopharyngeal Neoplasms | 2.1% |
| 460 | Pleural Effusion, Malignant | 2.1% |
| 461 | Hypopharyngeal Cancer | 2.1% |
| 462 | Serum Sickness | 2% |
| 463 | Anemia, Diamond-Blackfan | 2% |
| 464 | Parotid Neoplasms | 2% |
| 465 | Prostatic Neoplasms, Castration-Resistant | 2% |
| 466 | Nelson Syndrome | 2% |
| 467 | anaphylaxis | 2% |
| 468 | Anemia, Hemolytic | 2% |
| 469 | Anemia, Macrocytic | 2% |
| 470 | Eosinophilia | 2% |
| 471 | Food Allergy | 2% |
| 472 | Hypoproteinemia | 2% |
| 473 | Leukopenia | 2% |
| 474 | Thrombocytopenia | 2% |
| 475 | Leukostasis | 2% |
| 476 | MYELODYSPLASTIC SYNDROME | 2% |
| 477 | Anaphylactic shock | 2% |
| 478 | Choroid Plexus Papilloma | 2% |
| 479 | Anemia, Sickle Cell | 1.8% |
| 480 | Thalassemia | 1.8% |
| 481 | Tonsillar Neoplasms | 1.8% |
| 482 | Cerebellar Neoplasms | 1.8% |
| 483 | Cecal Neoplasms | 1.8% |
| 484 | Duodenal Neoplasms | 1.8% |
| 485 | Respiratory Hypersensitivity | 1.7% |
| 486 | Anemia, Neonatal | 1.7% |
| 487 | Leukocytosis | 1.7% |
| 488 | Pelger-Huet Anomaly | 1.7% |
| 489 | Sick Building Syndrome | 1.7% |
| 490 | Pleocytosis | 1.7% |
| 491 | Multiple Chemical Sensitivity | 1.7% |
| 492 | Urticaria | 1.6% |
| 493 | Vasculitis, Leukocytoclastic, Cutaneous | 1.6% |
| 494 | Nasopharyngeal Neoplasms | 1.6% |
| 495 | HTLV-I Infections | 1.6% |
| 496 | Colorectal Neoplasms | 1.6% |
| 497 | Radicular Cyst | 1.6% |
| 498 | Appendiceal Neoplasms | 1.6% |
| 499 | Colonic Neoplasms | 1.6% |
| 500 | Rectal Neoplasms | 1.6% |
| 501 | Ataxia Telangiectasia | 1.5% |
| 502 | Paranasal Sinus Neoplasms | 1.5% |
| 503 | Purpura, Hyperglobulinemic | 1.4% |
| 504 | Myasthenia Gravis | 1.4% |
| 505 | Uveomeningoencephalitic Syndrome | 1.4% |
| 506 | Hemolytic-Uremic Syndrome | 1.4% |
| 507 | Drug Eruptions | 1.4% |
| 508 | Ecchymosis | 1.4% |
| 509 | Petechiae | 1.4% |
| 510 | Purpura | 1.4% |
| 511 | Granulomatosis with polyangiitis | 1.4% |
| 512 | Dermatitis, Allergic Contact | 1.4% |
| 513 | HIV Seropositivity | 1.4% |
| 514 | Anus Neoplasms | 1.4% |
| 515 | Sigmoid Neoplasms | 1.4% |
| 516 | Maxillary Sinus Neoplasms | 1.3% |
| 517 | Sickle Cell Trait | 1.3% |
| 518 | Primary Myelofibrosis | 1.3% |
| 519 | Agranulocytosis | 1.3% |
| 520 | Anemia, Megaloblastic | 1.3% |
| 521 | Lymphocytosis | 1.3% |
| 522 | Myelofibrosis | 1.3% |
| 523 | Myeloid Metaplasia | 1.3% |
| 524 | Milk Allergy | 1.3% |
| 525 | Hypoalbuminemia | 1.3% |
| 526 | Myasthenia Gravis, Autoimmune, Experimental | 1.3% |
| 527 | Wheat Hypersensitivity | 1.3% |
| 528 | Hypereosinophilic syndrome | 1.3% |
| 529 | bone marrow fibrosis | 1.3% |
| 530 | Thrombotic Microangiopathies | 1.3% |
| 531 | Stiff-Person Syndrome | 1.3% |
| 532 | Polyradiculoneuropathy | 1.3% |
| 533 | Polyradiculoneuritis | 1.3% |
| 534 | Waterhouse-Friderichsen Syndrome | 1.2% |
| 535 | Acquired Immunodeficiency Syndrome | 1.2% |
| 536 | AIDS related complex | 1.2% |
| 537 | Felty Syndrome | 1.2% |
| 538 | Fanconi Anemia | 1.2% |
| 539 | Lupus Nephritis | 1.2% |
| 540 | AIDS-Related Opportunistic Infections | 1.1% |
| 541 | Vasculitis, Central Nervous System | 1.1% |
| 542 | Atypical Hemolytic Uremic Syndrome | 1.1% |
| 543 | Dermatitis, Atopic | 1.1% |
| 544 | HIV Wasting Syndrome | 1.1% |
| 545 | Rheumatoid Vasculitis | 1.1% |
| 546 | AIDS Dementia Complex | 1.1% |
| 547 | AIDS-Associated Nephropathy | 1.1% |
| 548 | Lupus Vasculitis, Central Nervous System | 1.1% |
| 549 | Acute Chest Syndrome | 1.1% |
| 550 | Niemann-Pick Disease, Type C | 1% |
| 551 | Sicca Syndrome | 1% |
| 552 | Sjogren's Syndrome | 1% |
| 553 | Neutropenia | 1% |
| 554 | HIV-Associated Lipodystrophy Syndrome | 1% |
| 555 | Neuromyelitis Optica | 1% |
| 556 | Eosinophilia-Myalgia Syndrome | 0.9% |
| 557 | Leukoencephalitis, Acute Hemorrhagic | 0.9% |
| 558 | Angioedema | 0.9% |
| 559 | Multiple Sclerosis | 0.9% |
| 560 | Shwartzman Phenomenon | 0.9% |
| 561 | Scurvy | 0.9% |
| 562 | Purpura Fulminans | 0.9% |
| 563 | Acute Generalized Exanthematous Pustulosis | 0.9% |
| 564 | Asthma | 0.8% |
| 565 | Pulmonary Eosinophilia | 0.8% |
| 566 | Eosinophilic Pneumonia | 0.8% |
| 567 | Encephalomyelitis, Acute Disseminated | 0.8% |
| 568 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.8% |
| 569 | Erythema Nodosum | 0.8% |
| 570 | Neuritis, Autoimmune, Experimental | 0.8% |
| 571 | Dermatitis, Photoallergic | 0.8% |
| 572 | Febrile Neutropenia | 0.8% |
| 573 | Anemia, Pernicious | 0.8% |
| 574 | Aspergillosis, Allergic Bronchopulmonary | 0.7% |
| 575 | Guillain-Barre Syndrome | 0.7% |
| 576 | Asthma, Exercise-Induced | 0.7% |
| 577 | Status Asthmaticus | 0.7% |
| 578 | Multiple Sclerosis, Chronic Progressive | 0.7% |
| 579 | Multiple Sclerosis, Relapsing-Remitting | 0.7% |
| 580 | Toxic Epidermal Necrolysis | 0.7% |
| 581 | Stevens-Johnson Syndrome | 0.7% |
| 582 | Asthma, Occupational | 0.6% |
| 583 | Farmer's Lung | 0.6% |
| 584 | Angioedemas, Hereditary | 0.6% |
| 585 | Hay fever | 0.6% |
| 586 | Rhinitis, Allergic, Perennial | 0.6% |
| 587 | Pseudoxanthoma Elasticum | 0.6% |
| 588 | Giant Cell Arteritis | 0.6% |
| 589 | Temporal Arteritis | 0.6% |
| 590 | Hereditary Angioedema Type III | 0.6% |
| 591 | Hereditary Angioedema Types I and II | 0.6% |
| 592 | Miller Fisher Syndrome | 0.4% |